The document discusses drug delivery, summarizing several key topics in the field. It provides an overview of the importance of drug delivery and some of the challenges like biological barriers and pharmacokinetic issues. It then highlights several recent research articles on targeted drug delivery using various nanoparticle carriers and formulations to overcome barriers and more effectively deliver drugs to specific sites.
Nanomaterial drug delivery updated 20202Tejas Pitale
The document discusses various types of nanoparticles that can be used for drug delivery, including spherical nanoparticles, nanotubes, nanocapsules, nanocrystalline drugs, nanogels, dendrimers, liposomes, polymeric micelles, and polymeric drug conjugates. It describes the properties and applications of each type of nanoparticle. Some key advantages of nanoparticles for drug delivery are their small size, ability to sequester drugs and provide controlled release, lower cytotoxicity, and potential for active targeting to sites in the body. Challenges to nanoparticle drug delivery include biological understanding, safety concerns, manufacturing difficulties, and targeting efficiency.
Metagenomics is the study of genetic material recovered directly from environmental samples without culturing. This field enables research on uncultured organisms and microbial communities. There are three main metagenomic approaches: biochemical, whole genome shotgun sequencing, and 16s rRNA sequencing. Metagenomics is being applied to study human microbiomes, discover new genes and enzymes, monitor environmental impacts, and characterize uncultured microbes. Future directions include identifying more novel products from uncultured bacteria and improving culture methods and bioinformatics tools.
This document discusses the role of nanoparticles in drug delivery. Nanoparticles can enhance drug delivery by allowing targeted delivery and controlled release of drugs. They interact more efficiently with cells and require lower dosages, reducing side effects. Various types of nanoparticles used for drug delivery include metal-based, lipid-based, and polymer-based nanoparticles. Nanoparticles must be optimally designed to avoid rapid clearance from the body and target delivery to specific sites. Continued improvements in controlled release and targeting will enable safer and more effective therapeutic nanoparticles.
Nanoparticles between 1-100 nanometers in size can be used to deliver drugs in the body. They allow changing the pharmacokinetic properties of drugs without altering the active compound. Biodegradable polymeric nanoparticles have attracted interest as potential drug carriers that can target specific organs and tissues and deliver proteins, peptides, and genes orally. Nanoparticles must be able to travel through blood vessels and cross cell layers to reach their target site. Their small size allows them to potentially penetrate tissues and cells to provide localized drug delivery.
This document discusses nanotechnology based drug delivery using nanoparticles. It defines nanoparticles as particulate distributions between 10-100 nm in size. Nanoparticles can be prepared from different materials and used to deliver drugs through controlled release and targeted delivery to diseased tissues. This allows for lower drug doses, reduced side effects, and improved drug solubility. The document discusses various nanoparticle types and aspects of passive and active drug targeting to specific sites. Overall, nanoparticles show potential for improving drug pharmacokinetics and delivery across biological barriers.
Nanotechnology involves processes at the molecular and nano-length scale. It has numerous applications in pharmacy, including as drug delivery systems using liposomes, dendrimers, nanoparticles, and nanotubes. Pharmaceutical nanotechnology provides nano-materials for tissue engineering and nano-devices like biosensors. Nano-materials are used for drug encapsulation, implants, and scaffolds. Nano-devices include biosensors, detectors, and potential "nano-robots". Current applications include medicine, tissue engineering, diagnostics, and imaging enhancement. Future prospects may include intelligent machines that detect, treat, and monitor disease simultaneously.
Nanoparticles for drug delivery by shreyaShreya Modi
This document discusses the advancement of nanotechnology and nanoparticles for cancer diagnosis and drug delivery. It outlines several challenges in developing effective nanoscale drug delivery systems, as well as properties of nanomaterials that make them suitable for drug delivery. Various nanodevices are described that could be used for targeted drug delivery, including liposomes, nanoshells, dendrimers, micelles, nanowires, nanotubes, quantum dots, and potential future nanorobots. Advantages of nanoparticle drug delivery systems include smaller size, higher bioavailability, and ability to target drugs directly to cells and nuclei. The only disadvantage mentioned is difficulty determining proper dosages.
Application of nano technology in medicinal and aromatic cropsChandrakant Ballolli
This document discusses the application of nanotechnology in medicinal and aromatic plants. It begins with an introduction to nanotechnology and its importance in fields such as biomedicine, sensors, electronics and agriculture. It then discusses some key applications of nanotechnology in MAPs such as drug delivery, biosynthesis of nanoparticles, and nanoemulsion preparation. Specific examples are provided of nanoparticles used for drug delivery from plants such as lemongrass. The biosynthesis of nanoparticles using plant extracts is also discussed. Finally, the use of nanotechnology in crop management applications like slow release of fertilizers and herbicides is summarized.
Nanomaterial drug delivery updated 20202Tejas Pitale
The document discusses various types of nanoparticles that can be used for drug delivery, including spherical nanoparticles, nanotubes, nanocapsules, nanocrystalline drugs, nanogels, dendrimers, liposomes, polymeric micelles, and polymeric drug conjugates. It describes the properties and applications of each type of nanoparticle. Some key advantages of nanoparticles for drug delivery are their small size, ability to sequester drugs and provide controlled release, lower cytotoxicity, and potential for active targeting to sites in the body. Challenges to nanoparticle drug delivery include biological understanding, safety concerns, manufacturing difficulties, and targeting efficiency.
Metagenomics is the study of genetic material recovered directly from environmental samples without culturing. This field enables research on uncultured organisms and microbial communities. There are three main metagenomic approaches: biochemical, whole genome shotgun sequencing, and 16s rRNA sequencing. Metagenomics is being applied to study human microbiomes, discover new genes and enzymes, monitor environmental impacts, and characterize uncultured microbes. Future directions include identifying more novel products from uncultured bacteria and improving culture methods and bioinformatics tools.
This document discusses the role of nanoparticles in drug delivery. Nanoparticles can enhance drug delivery by allowing targeted delivery and controlled release of drugs. They interact more efficiently with cells and require lower dosages, reducing side effects. Various types of nanoparticles used for drug delivery include metal-based, lipid-based, and polymer-based nanoparticles. Nanoparticles must be optimally designed to avoid rapid clearance from the body and target delivery to specific sites. Continued improvements in controlled release and targeting will enable safer and more effective therapeutic nanoparticles.
Nanoparticles between 1-100 nanometers in size can be used to deliver drugs in the body. They allow changing the pharmacokinetic properties of drugs without altering the active compound. Biodegradable polymeric nanoparticles have attracted interest as potential drug carriers that can target specific organs and tissues and deliver proteins, peptides, and genes orally. Nanoparticles must be able to travel through blood vessels and cross cell layers to reach their target site. Their small size allows them to potentially penetrate tissues and cells to provide localized drug delivery.
This document discusses nanotechnology based drug delivery using nanoparticles. It defines nanoparticles as particulate distributions between 10-100 nm in size. Nanoparticles can be prepared from different materials and used to deliver drugs through controlled release and targeted delivery to diseased tissues. This allows for lower drug doses, reduced side effects, and improved drug solubility. The document discusses various nanoparticle types and aspects of passive and active drug targeting to specific sites. Overall, nanoparticles show potential for improving drug pharmacokinetics and delivery across biological barriers.
Nanotechnology involves processes at the molecular and nano-length scale. It has numerous applications in pharmacy, including as drug delivery systems using liposomes, dendrimers, nanoparticles, and nanotubes. Pharmaceutical nanotechnology provides nano-materials for tissue engineering and nano-devices like biosensors. Nano-materials are used for drug encapsulation, implants, and scaffolds. Nano-devices include biosensors, detectors, and potential "nano-robots". Current applications include medicine, tissue engineering, diagnostics, and imaging enhancement. Future prospects may include intelligent machines that detect, treat, and monitor disease simultaneously.
Nanoparticles for drug delivery by shreyaShreya Modi
This document discusses the advancement of nanotechnology and nanoparticles for cancer diagnosis and drug delivery. It outlines several challenges in developing effective nanoscale drug delivery systems, as well as properties of nanomaterials that make them suitable for drug delivery. Various nanodevices are described that could be used for targeted drug delivery, including liposomes, nanoshells, dendrimers, micelles, nanowires, nanotubes, quantum dots, and potential future nanorobots. Advantages of nanoparticle drug delivery systems include smaller size, higher bioavailability, and ability to target drugs directly to cells and nuclei. The only disadvantage mentioned is difficulty determining proper dosages.
Application of nano technology in medicinal and aromatic cropsChandrakant Ballolli
This document discusses the application of nanotechnology in medicinal and aromatic plants. It begins with an introduction to nanotechnology and its importance in fields such as biomedicine, sensors, electronics and agriculture. It then discusses some key applications of nanotechnology in MAPs such as drug delivery, biosynthesis of nanoparticles, and nanoemulsion preparation. Specific examples are provided of nanoparticles used for drug delivery from plants such as lemongrass. The biosynthesis of nanoparticles using plant extracts is also discussed. Finally, the use of nanotechnology in crop management applications like slow release of fertilizers and herbicides is summarized.
Nanotechnology is science, engineering, and technology conducted at the nanoscale, which is about 1 to 100 nanometers. Physicist Richard Feynman, the father of nanotechnology.
Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body some time based on nanoparticles as needed to safely achieve its desired therapeutic effect.
Tissue engineering is a biomedical engineering discipline that uses a combination of cells, engineering, materials methods, and suitable biochemical and physicochemical factors to restore, maintain, improve, or replace different types of biological tissues.
- Nanomedicine shows promise as a field of nanotechnology for non-invasive diagnostic imaging, tumor detection, and targeted drug delivery using unique properties of nanoparticles.
- Nanoparticles for drug delivery can be spherical vesicles like liposomes or polymeric nanoparticles, which allow drugs to be attached or incorporated for more effective administration and bioavailability than traditional methods.
- After nanoparticles transport drugs to targeted sites, the drugs are released through various mechanisms to produce therapeutic effects in a sustained and protected manner.
Nanoparticle Drug Delivery Systems for Cancer TreatmentAranca
The engineered nanoparticles are effectively used for cancer treatment due to their targeted drug delivery approach. Download the Aranca report on Technology and Patent Research for current research trends and developments.
ABSTRACT- Present work explores the novel selenium nanoparticle-enhanced photodynamic therapy of toluidine blue
O against Streptococcus mutans biofilm. Physiochemical (Ultraviolet-visible absorption, FTIR, and fluorescence
spectroscopy) and Electron microscopy techniques were used to characterize selenium nanoparticles. The UV spectrum
of different concentrations of SeNP were showed distinct peak at ~288 nm, which confirmed the successful synthesis of
SeNP in this study. The synthesized Selenium nanoparticles were uniform and spherical in shape with average size
~100 nm. In FTIR spectra of SeNPs there were strong absorption band around 3425cm-1, 2928 cm-1 and 1647 cm-1.
TBO showed MIC and MBC of 62.5 μg/mL and 125 μg/mL respectively whereas in presence of SeNPs showed MIC
and MBC of 31.25 μg/mL and MBC of 62.5 μg/mL. SeNPs–TBO conjugate showed twofold higher activities against S
mutans than TBO alone. A 630 nm diode laser was applied for activation of SeNP- Toluidine blue O (TBO)
combination and TBO against S. mutans biofilm and cells. The UV-vis absorption result suggests that TBO is not
present on the surface of SeNP. In fluorescence emission spectra, there is enhancement of fluorescence of TBO
fluorescence in the presence of nanoparticle. This showed that SeNP are enhancing the photodynamic therapy.
Antibiofilm assays and microscopic studies showed significant reduction of biofilm presence of conjugate. A crystal
violet assay revealed a maximum percent inhibition of S. mutans biofilm formation after 24 hours’ incubation, recorded
as 20% and 60% by TBO (31.25 μg/mL) and SeNP–TBO (31.25 μg/mL; TBO) conjugate, respectively. XTT biofilm
reduction assay were showed 32% loss in viability in presence of SeNP-TBO conjugate whereas in presence of only
TBO there was 22% loss in viability of cells. Fluorescence spectroscopic study confirmed type I photo toxicity against
biofilm. Selenium nanoparticle conjugate–mediated photodynamic therapy may be used against recalcitrant biofilm
based infections and can be helpful in dentistry.
Key-words- S. mutans, SeNP, TBO, UV absorption, FTIR, fluorescence spectroscopy
This document discusses the role of nanotechnology in pharmacology and drug delivery. It begins with definitions of nanotechnology and nanobiotechnology, then describes applications of nanobiotechnology including nanopharmacology. The key roles of nanotechnology in drug discovery and development, and drug delivery systems are summarized. Specific nanocarrier platforms like liposomes, polymeric nanoparticles, dendrimers, and nanocrystals are discussed in terms of their advantages and challenges for drug delivery. The role of nanodrugs in personalized medicine is also mentioned.
NANO TECHNOLOGY IN DRUG DELIVERY SYSTEMsathish sak
Nanotechnology uses structures sized 100 nm or smaller to develop drug delivery systems. Nanoparticles made from metals, lipids, polymers, or biological materials can encapsulate drugs and transport them in the body. Lipid nanoparticles like liposomes are biocompatible and protect drugs, allowing targeted delivery. Polymer nanoparticles like dendrimers and micelles also encapsulate drugs. Nanotechnology overcomes obstacles like the blood-brain barrier and can uniformly deliver drugs while sustaining their release and preventing degradation. Problems in drug delivery like poor oral availability are addressed through these nanoscale drug carriers.
This document summarizes the current status of research on enediyne natural products, which are a class of antitumor antibiotics with an unusual bicyclo or biocyclo core structure. It reviews methods for cloning the biosynthetic gene clusters responsible for enediyne production. It then presents a unified paradigm for enediyne biosynthesis involving polyketide synthase enzymes, accessory enzymes, and tailoring enzymes. Finally, it discusses strategies for applying combinatorial biosynthesis techniques to engineer novel enediyne analogs with the goal of developing new antitumor agents.
The emergence of nanotechnology is likely to have a significant impact on drug delivery sector, affecting just about every route of administration from oral to injectable, according to specialist market research firm NanoMarkets.
Drug delivery involves transporting pharmaceutical compounds in the body to safely achieve their desired effects using technologies and systems. It concerns both the quantity and duration of drug presence. For example, protein drugs must be delivered via injection or nano-needles. Nanoparticles like liposomes, dendrimers, fullerenes, nanoshells, quantum dots, and nanorobots can provide targeted drug delivery, improved solubility, constant drug release rates, and increased stability.
- Biomagnification refers to the increasing concentration of chemicals or toxins in organisms at higher levels of the food chain. Nanoparticles used in nanofungicides can potentially biomagnify due to their persistence, ability to accumulate in organisms, and low degradation rates.
- Nanoparticles can enter plants directly through soil, water and air or systemically through the use of nano-based agricultural chemicals. Once inside plants, nanoparticles can cause toxicity, hormone imbalances, and accumulation in plant cells and tissues.
- For safe use of nanotechnology in agriculture, more studies on nanoparticle impacts are needed. Biodegradable nanoparticles should be developed and thorough safety testing of nano-products conducted to prevent biom
This document discusses genetic manipulation of carotenoid biosynthesis. It defines genetic engineering as the direct manipulation of an organism's genes using techniques like recombinant DNA and gene splicing. It explains that genetic manipulation can be used to alter existing species' characteristics or induce mutations to produce desirable traits. Specific techniques discussed include site-directed mutagenesis, protoplast fusion, and using shuttle and expression vectors. Carotenoids are described as pigments that protect plant structures and have health benefits when consumed by humans as antioxidants and for vitamin A activity. The locations and functions of carotenoid pigments are summarized.
RECENT ADVANCES IN MICRO AND NANO DRUG DELIVERY SYSTEMSVijitha J
This document discusses recent advances in micro and nano drug delivery systems. It describes how nanomedicine uses nanoparticles smaller than 100nm for diagnosis, treatment, and prevention of diseases. Various types of nanoparticles are discussed for drug delivery, including metal-based, lipid-based, polymer-based, and biological nanoparticles. Specific examples provided include gold nanoparticles that can self-assemble into plasmonic vesicles for stimuli-responsive drug release, silica-gold nanoshells for thermal ablation of cancer cells, and liposomes for encapsulation of both hydrophobic and hydrophilic drugs. The mechanisms of polymeric nanoparticles, lipid nanoparticles, and chitosan carriers for drug delivery are also summarized. The document concludes by discussing the potential of nanoparticles for
1) Researchers are investigating a therapeutic approach for treating multi-drug resistant triple negative breast cancer by manipulating mitochondrial networks.
2) They developed liposomes containing a peptide that breaks up mitochondrial fusion and tested them on cancer cells along with drugs to induce cell death.
3) Preliminary results found the mitochondrial-targeting peptide was effective at breaking up fusion in drug-resistant cancer cells, suggesting this approach may provide a treatment for multi-drug resistant breast cancer.
NANO TECHNOLOGY IN DRUG DELIVERY SYSTEMsathish sak
This document discusses how nanoparticles can be used for targeted drug delivery in cancer and inflammation. Nanoparticles less than 100nm in size can be engineered from biodegradable materials to efficiently carry drugs and be taken up by targeted cells. They allow for higher doses of drugs to be delivered directly to diseased cells over prolonged periods of time, reducing side effects. Examples discussed include using nanoparticles to target cancer cells, tumor angiogenesis, infected macrophages, and inflammatory molecules. The future potential of nanotechnology for improved targeted drug delivery is promising.
The field of nanotechnology was first Discovered by Professor Richard P. Feynman in 1959 (Nobel laureate in physics, 1965) [2]. Nanotechnology is the science of the small; very small and it is used for the management of substance at a small scale. At this size, molecules and atoms work in a different way, and provide a variety of unpredicted and attractive uses .
This document summarizes the multi-step process of developing new drugs, from identifying protein targets to modifying lead compounds. It involves screening large libraries of molecules, identifying initial "hits" that bind to the target, developing the hits into "leads" through testing and modification, and optimizing leads into drug candidates through medicinal chemistry. Key techniques discussed include fragment-based drug discovery using X-ray crystallography at synchrotrons to visualize how compounds interact with proteins, and synthetic organic chemistry approaches to modify compounds' properties and potency. The process typically involves designing, synthesizing, and testing hundreds of compounds over many years before a new drug can reach the market.
This document discusses various topics related to pharmaceutical technology and polymerization, including:
1. It introduces interfacial polymerization and microencapsulation using two types of polymerization - in-situ and interfacial polymerization.
2. It then discusses sustained release drug delivery systems, highlighting matrix tablets as a common approach and factors that influence drug release.
3. Finally, it covers reservoir-based drug delivery systems, describing benefits, classes, development approaches, and common polymers used including non-biodegradable and biodegradable options.
This document lists 17 publications by Megan Robinson from 1990 to 2006 related to her research on topoisomerase II and mitogen-activated protein kinases (MAPKs). Her early work studied the effects of antineoplastic drugs on topoisomerase II and how they stabilize DNA cleavage complexes. Later publications investigated the roles and regulation of MAPKs ERK2 and ERK3, including their subcellular localization and effects on neurite outgrowth and cell transformation. She also authored review articles and book chapters on topoisomerase II mechanisms and MAPK pathways.
This document introduces a companion website for a biochemistry textbook. It provides the following key information:
1. The website accompanies the third edition of a biochemistry textbook by Mathews, van Holde, and Ahern.
2. The website contains outlines, concepts, terminology, and quizzing for each textbook chapter to help students learn biochemistry.
3. The same material on the website is also available on a CD-ROM included with the textbook for offline use.
4. The website provides links between concepts covered and related external websites for expanded information.
Use of nanotechnology in antimicrobial R&D- Students Against (SAS) Superbugs ...JimmyNkaiwuatei
Uploaded date: September 17th, 2022
This was a presentation offered by Faith Zablon during an educational Workshop to Students Against Superbugs Africa on September 17th, 2022.
This presentation was uploaded on behalf of Students Against Superbugs Africa.
Application of nanoparticals in drug delivery systemMalay Jivani
This document discusses nanoparticles and their applications in pharmaceuticals, with a focus on using gold nanoparticles (AuNPs) for cancer treatment. It defines nanoparticles and describes some common preparation methods. It then discusses several potential medical applications of nanoparticles, including using them as delivery systems for drugs, genes, and targeting cancer cells. Specifically for AuNPs, it covers their synthesis, properties, and how their surfaces can be functionalized. It describes how AuNPs may be useful for photothermal therapy, radiotherapy, and inhibiting angiogenesis for cancer treatment.
Nanotechnology is science, engineering, and technology conducted at the nanoscale, which is about 1 to 100 nanometers. Physicist Richard Feynman, the father of nanotechnology.
Drug delivery refers to approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body some time based on nanoparticles as needed to safely achieve its desired therapeutic effect.
Tissue engineering is a biomedical engineering discipline that uses a combination of cells, engineering, materials methods, and suitable biochemical and physicochemical factors to restore, maintain, improve, or replace different types of biological tissues.
- Nanomedicine shows promise as a field of nanotechnology for non-invasive diagnostic imaging, tumor detection, and targeted drug delivery using unique properties of nanoparticles.
- Nanoparticles for drug delivery can be spherical vesicles like liposomes or polymeric nanoparticles, which allow drugs to be attached or incorporated for more effective administration and bioavailability than traditional methods.
- After nanoparticles transport drugs to targeted sites, the drugs are released through various mechanisms to produce therapeutic effects in a sustained and protected manner.
Nanoparticle Drug Delivery Systems for Cancer TreatmentAranca
The engineered nanoparticles are effectively used for cancer treatment due to their targeted drug delivery approach. Download the Aranca report on Technology and Patent Research for current research trends and developments.
ABSTRACT- Present work explores the novel selenium nanoparticle-enhanced photodynamic therapy of toluidine blue
O against Streptococcus mutans biofilm. Physiochemical (Ultraviolet-visible absorption, FTIR, and fluorescence
spectroscopy) and Electron microscopy techniques were used to characterize selenium nanoparticles. The UV spectrum
of different concentrations of SeNP were showed distinct peak at ~288 nm, which confirmed the successful synthesis of
SeNP in this study. The synthesized Selenium nanoparticles were uniform and spherical in shape with average size
~100 nm. In FTIR spectra of SeNPs there were strong absorption band around 3425cm-1, 2928 cm-1 and 1647 cm-1.
TBO showed MIC and MBC of 62.5 μg/mL and 125 μg/mL respectively whereas in presence of SeNPs showed MIC
and MBC of 31.25 μg/mL and MBC of 62.5 μg/mL. SeNPs–TBO conjugate showed twofold higher activities against S
mutans than TBO alone. A 630 nm diode laser was applied for activation of SeNP- Toluidine blue O (TBO)
combination and TBO against S. mutans biofilm and cells. The UV-vis absorption result suggests that TBO is not
present on the surface of SeNP. In fluorescence emission spectra, there is enhancement of fluorescence of TBO
fluorescence in the presence of nanoparticle. This showed that SeNP are enhancing the photodynamic therapy.
Antibiofilm assays and microscopic studies showed significant reduction of biofilm presence of conjugate. A crystal
violet assay revealed a maximum percent inhibition of S. mutans biofilm formation after 24 hours’ incubation, recorded
as 20% and 60% by TBO (31.25 μg/mL) and SeNP–TBO (31.25 μg/mL; TBO) conjugate, respectively. XTT biofilm
reduction assay were showed 32% loss in viability in presence of SeNP-TBO conjugate whereas in presence of only
TBO there was 22% loss in viability of cells. Fluorescence spectroscopic study confirmed type I photo toxicity against
biofilm. Selenium nanoparticle conjugate–mediated photodynamic therapy may be used against recalcitrant biofilm
based infections and can be helpful in dentistry.
Key-words- S. mutans, SeNP, TBO, UV absorption, FTIR, fluorescence spectroscopy
This document discusses the role of nanotechnology in pharmacology and drug delivery. It begins with definitions of nanotechnology and nanobiotechnology, then describes applications of nanobiotechnology including nanopharmacology. The key roles of nanotechnology in drug discovery and development, and drug delivery systems are summarized. Specific nanocarrier platforms like liposomes, polymeric nanoparticles, dendrimers, and nanocrystals are discussed in terms of their advantages and challenges for drug delivery. The role of nanodrugs in personalized medicine is also mentioned.
NANO TECHNOLOGY IN DRUG DELIVERY SYSTEMsathish sak
Nanotechnology uses structures sized 100 nm or smaller to develop drug delivery systems. Nanoparticles made from metals, lipids, polymers, or biological materials can encapsulate drugs and transport them in the body. Lipid nanoparticles like liposomes are biocompatible and protect drugs, allowing targeted delivery. Polymer nanoparticles like dendrimers and micelles also encapsulate drugs. Nanotechnology overcomes obstacles like the blood-brain barrier and can uniformly deliver drugs while sustaining their release and preventing degradation. Problems in drug delivery like poor oral availability are addressed through these nanoscale drug carriers.
This document summarizes the current status of research on enediyne natural products, which are a class of antitumor antibiotics with an unusual bicyclo or biocyclo core structure. It reviews methods for cloning the biosynthetic gene clusters responsible for enediyne production. It then presents a unified paradigm for enediyne biosynthesis involving polyketide synthase enzymes, accessory enzymes, and tailoring enzymes. Finally, it discusses strategies for applying combinatorial biosynthesis techniques to engineer novel enediyne analogs with the goal of developing new antitumor agents.
The emergence of nanotechnology is likely to have a significant impact on drug delivery sector, affecting just about every route of administration from oral to injectable, according to specialist market research firm NanoMarkets.
Drug delivery involves transporting pharmaceutical compounds in the body to safely achieve their desired effects using technologies and systems. It concerns both the quantity and duration of drug presence. For example, protein drugs must be delivered via injection or nano-needles. Nanoparticles like liposomes, dendrimers, fullerenes, nanoshells, quantum dots, and nanorobots can provide targeted drug delivery, improved solubility, constant drug release rates, and increased stability.
- Biomagnification refers to the increasing concentration of chemicals or toxins in organisms at higher levels of the food chain. Nanoparticles used in nanofungicides can potentially biomagnify due to their persistence, ability to accumulate in organisms, and low degradation rates.
- Nanoparticles can enter plants directly through soil, water and air or systemically through the use of nano-based agricultural chemicals. Once inside plants, nanoparticles can cause toxicity, hormone imbalances, and accumulation in plant cells and tissues.
- For safe use of nanotechnology in agriculture, more studies on nanoparticle impacts are needed. Biodegradable nanoparticles should be developed and thorough safety testing of nano-products conducted to prevent biom
This document discusses genetic manipulation of carotenoid biosynthesis. It defines genetic engineering as the direct manipulation of an organism's genes using techniques like recombinant DNA and gene splicing. It explains that genetic manipulation can be used to alter existing species' characteristics or induce mutations to produce desirable traits. Specific techniques discussed include site-directed mutagenesis, protoplast fusion, and using shuttle and expression vectors. Carotenoids are described as pigments that protect plant structures and have health benefits when consumed by humans as antioxidants and for vitamin A activity. The locations and functions of carotenoid pigments are summarized.
RECENT ADVANCES IN MICRO AND NANO DRUG DELIVERY SYSTEMSVijitha J
This document discusses recent advances in micro and nano drug delivery systems. It describes how nanomedicine uses nanoparticles smaller than 100nm for diagnosis, treatment, and prevention of diseases. Various types of nanoparticles are discussed for drug delivery, including metal-based, lipid-based, polymer-based, and biological nanoparticles. Specific examples provided include gold nanoparticles that can self-assemble into plasmonic vesicles for stimuli-responsive drug release, silica-gold nanoshells for thermal ablation of cancer cells, and liposomes for encapsulation of both hydrophobic and hydrophilic drugs. The mechanisms of polymeric nanoparticles, lipid nanoparticles, and chitosan carriers for drug delivery are also summarized. The document concludes by discussing the potential of nanoparticles for
1) Researchers are investigating a therapeutic approach for treating multi-drug resistant triple negative breast cancer by manipulating mitochondrial networks.
2) They developed liposomes containing a peptide that breaks up mitochondrial fusion and tested them on cancer cells along with drugs to induce cell death.
3) Preliminary results found the mitochondrial-targeting peptide was effective at breaking up fusion in drug-resistant cancer cells, suggesting this approach may provide a treatment for multi-drug resistant breast cancer.
NANO TECHNOLOGY IN DRUG DELIVERY SYSTEMsathish sak
This document discusses how nanoparticles can be used for targeted drug delivery in cancer and inflammation. Nanoparticles less than 100nm in size can be engineered from biodegradable materials to efficiently carry drugs and be taken up by targeted cells. They allow for higher doses of drugs to be delivered directly to diseased cells over prolonged periods of time, reducing side effects. Examples discussed include using nanoparticles to target cancer cells, tumor angiogenesis, infected macrophages, and inflammatory molecules. The future potential of nanotechnology for improved targeted drug delivery is promising.
The field of nanotechnology was first Discovered by Professor Richard P. Feynman in 1959 (Nobel laureate in physics, 1965) [2]. Nanotechnology is the science of the small; very small and it is used for the management of substance at a small scale. At this size, molecules and atoms work in a different way, and provide a variety of unpredicted and attractive uses .
This document summarizes the multi-step process of developing new drugs, from identifying protein targets to modifying lead compounds. It involves screening large libraries of molecules, identifying initial "hits" that bind to the target, developing the hits into "leads" through testing and modification, and optimizing leads into drug candidates through medicinal chemistry. Key techniques discussed include fragment-based drug discovery using X-ray crystallography at synchrotrons to visualize how compounds interact with proteins, and synthetic organic chemistry approaches to modify compounds' properties and potency. The process typically involves designing, synthesizing, and testing hundreds of compounds over many years before a new drug can reach the market.
This document discusses various topics related to pharmaceutical technology and polymerization, including:
1. It introduces interfacial polymerization and microencapsulation using two types of polymerization - in-situ and interfacial polymerization.
2. It then discusses sustained release drug delivery systems, highlighting matrix tablets as a common approach and factors that influence drug release.
3. Finally, it covers reservoir-based drug delivery systems, describing benefits, classes, development approaches, and common polymers used including non-biodegradable and biodegradable options.
This document lists 17 publications by Megan Robinson from 1990 to 2006 related to her research on topoisomerase II and mitogen-activated protein kinases (MAPKs). Her early work studied the effects of antineoplastic drugs on topoisomerase II and how they stabilize DNA cleavage complexes. Later publications investigated the roles and regulation of MAPKs ERK2 and ERK3, including their subcellular localization and effects on neurite outgrowth and cell transformation. She also authored review articles and book chapters on topoisomerase II mechanisms and MAPK pathways.
This document introduces a companion website for a biochemistry textbook. It provides the following key information:
1. The website accompanies the third edition of a biochemistry textbook by Mathews, van Holde, and Ahern.
2. The website contains outlines, concepts, terminology, and quizzing for each textbook chapter to help students learn biochemistry.
3. The same material on the website is also available on a CD-ROM included with the textbook for offline use.
4. The website provides links between concepts covered and related external websites for expanded information.
Use of nanotechnology in antimicrobial R&D- Students Against (SAS) Superbugs ...JimmyNkaiwuatei
Uploaded date: September 17th, 2022
This was a presentation offered by Faith Zablon during an educational Workshop to Students Against Superbugs Africa on September 17th, 2022.
This presentation was uploaded on behalf of Students Against Superbugs Africa.
Application of nanoparticals in drug delivery systemMalay Jivani
This document discusses nanoparticles and their applications in pharmaceuticals, with a focus on using gold nanoparticles (AuNPs) for cancer treatment. It defines nanoparticles and describes some common preparation methods. It then discusses several potential medical applications of nanoparticles, including using them as delivery systems for drugs, genes, and targeting cancer cells. Specifically for AuNPs, it covers their synthesis, properties, and how their surfaces can be functionalized. It describes how AuNPs may be useful for photothermal therapy, radiotherapy, and inhibiting angiogenesis for cancer treatment.
The engineered nanoparticles are effectively used for cancer treatment due to their targeted drug delivery approach. Download the Aranca report on Technology and Patent Research for current research trends and developments.
This document discusses using nanocomposites for cancer immunotherapy. It describes how tumors evade the immune system through inhibitory cytokines and loss of antigen processing. Current cancer treatments like chemotherapy and radiation have toxicity issues and limited effectiveness. The document proposes using dendritic cell-based immunotherapy as a safer alternative that utilizes the patient's immune system to fight cancer. It reviews literature on using pH-responsive nanoparticles, liposomes, and nanoparticles co-encapsulated with TLR agonists to target dendritic cells and enhance antigen presentation and immune responses, showing potential for effective cancer treatment.
This document discusses using nanocomposites for immunotherapy. It describes how tumors escape immune detection through inhibitory cytokines and dysfunctional dendritic cells. Current cancer treatments like chemotherapy and radiation have limitations like toxicity and inability to completely remove tumors or prevent recurrence. The document proposes immunotherapy using dendritic cell-based approaches as a safer alternative that could eliminate tumors via natural immune responses with less toxicity and risk of recurrence. It reviews literature on pH-responsive nanoparticles that effectively deliver antigens to induce immune responses. Different studies demonstrated dendritic cell targeting nanoparticles improved cancer immunotherapy outcomes in animal models.
A General Overview of Nano Medicine-Efficacy in Therapeutic Science and Curre...ceijjournals
Nanotechnology’s introduction has dramatically improved a number of scientific fields, one of which is
medicinal research. Nanomedicine is aimed to offer healthcare medications and chemicals a new
dimension. The small size of nanoparticles, permits them to circulate in the body without interrupting
oxygenation and escape filtration by both the renal and gastrointestinal networks. These are the few
properties that distinguish them apart from traditional therapeutic procedures. The increased permeability
and durability effect result in successful penetration inside the tumor tissues, providing cancer treatment a
new lease on life. Efficient transportation pathways, on the other hand, produce genotoxicity and
mutagenicity by interacting with genes that are essential for smooth functioning. As the specific
interactions of nanomedicines with biological systems are still unknown, comprehending nanomedicines'
toxicological effects is tough. The lack of regulatory direction in this field remains a research gap that we
would want to examine in this study.
A General Overview of Nano Medicine-Efficacy in Therapeutic Science and Curre...Berklin
Nanotechnology’s introduction has dramatically improved a number of scientific fields, one of which is medicinal research. Nanomedicine is aimed to offer healthcare medications and chemicals a new dimension. The small size of nanoparticles, permits them to circulate in the body without interrupting oxygenation and escape filtration by both the renal and gastrointestinal networks. These are the few properties that distinguish them apart from traditional therapeutic procedures. The increased permeability and durability effect result in successful penetration inside the tumor tissues, providing cancer treatment a new lease on life. Efficient transportation pathways, on the other hand, produce genotoxicity and mutagenicity by interacting with genes that are essential for smooth functioning. As the specific interactions of nanomedicines with biological systems are still unknown, comprehending nanomedicines' toxicological effects is tough. The lack of regulatory direction in this field remains a research gap that we would want to examine in this study.
Relative Properties and Relative Potency of Various Hydrazide Compounds That ...IOSRJPBS
This document summarizes the molecular properties and relative potency of various hydrazide compounds that inhibit the growth of Mycobacterium tuberculosis. It describes the molecular structures of nine hydrazide compounds tested, including isoniazid. It analyzes the compounds' molecular properties like Log P, polar surface area, molecular weight, and number of atoms. All compounds showed zero violations of the "Rule of 5" indicating favorable drug-likeness. Minimum inhibitory concentrations ranged from 16.7 to 65.9 ug/mL. Estimated brain penetration (Log BB) was calculated and no outliers were found. Overall, the compounds exhibited variation in properties but remained favorable for inhibiting tuberculosis growth.
Nanotechnology involves controlling and manipulating matter at the atomic and molecular scale from 1-100 nm. It allows the production of materials and devices with special properties not seen in bulk materials. Nanoparticles can be synthesized through various methods and engineered into different structures. Nanomedicine applies nanotechnology for health and medicine, enabling early disease detection and more targeted treatment through nano-sized materials and biosensors. In cancer treatment, nanoparticles can be engineered to target and deliver chemotherapeutics directly to tumor cells to minimize side effects.
Antitumor applications of nano-traditional Chinese medicineLucyPi1
An article by Deng et al. [1] that was first published in ACS Nano in 2019 revealed that nanoparticles extracted from cuttlefish ink (CINPs) could inhibit tumor growth by synergizing immunotherapy and photothermal therapy. The researchers found that these CINPs, which had significant antitumor efficacy, could effectively reprogram tumor-associated macrophages (TAMs) from the immune-suppressive M2-like phenotype to the antitumor M1-like phenotype.
Mycobacterium Tuberculosis cause severe disease of lungs known as Tuberculosis. It is a major cause
of morbidity and mortality even in the emerging countries also. However, to prepare an antibiotics drug against Mycobacterium tuberculosis is a major challenge
The document discusses various types of nanoparticles used in nanomedicine, including their properties and applications. It describes how nanoparticles can accumulate in tumors via the enhanced permeability and retention effect. Different classes of nanoparticles are described, such as liposomes, polymers, inorganic nanoparticles, and extracellular vesicles like exosomes. The advantages of these nanoparticles for drug delivery, imaging, and theranostics are summarized. Key factors that influence the behavior of nanoparticles in the body like size, shape, surface properties are also discussed.
Synthesis and Evaluation of the Cytotoxic and Anti-Proliferative Properties o...IJEAB
Doxorubicin (Dox) is a potent chemotherapeutic agent used in the treatment of cancer. In the present study, pH responsive chitosan polymer coated Dox nanoparticle (Composite) was developed to investigate targeted drug delivery against breast cancer. The anticancer drug DOX-ZnO QDs was loaded to the chitosan nanoparticles. The synthesized free and drug loaded nanoparticle were analyzed using Fourier transmission electron microscopy (FTIR) and UV-Visible spectroscopy(UV-Vis). The particle size was measured using Transmission Electron Microscopy (TEM). Further, the composite was evaluated for its anticancer effects. Drug release analysis showed significantly larger amount of drug released in acidic pH of 5.0 compared to pH 7.4. The composite was significantly more cytotoxic to the breast cancer cells MCF-7 and SKBR-3. The composite was however, less toxic to HEK-293 human embryonic kidney cells confirming minimum side effects on normal cells andcytotoxic to tumor cells. DAPI staining showed nuclear degradation in composite treated breast cancer cells. The cellular uptake of the composite was analyzed by confocal microscopy. The composite induced a G0/G1 phase arrest in breast cancer cells and the number of colonies formed by the composite treated breast cancer cells formed less number of colonies compared to free NP. Our results showed that our composite could serve as a promising therapeutic approach to improve clinical outcomes against various malignancies.
Nanotechnology for cancer therapy recent developmentsroshan telrandhe
1. The document discusses recent developments in using nanotechnology for cancer therapy. It describes how nanoparticles can be used to target delivery of drugs specifically to tumor cells, reducing side effects on healthy cells.
2. Various nanotechnology platforms for drug delivery are reviewed, including polymeric nanoparticles, liposomes, dendrimers, and nucleic acid-based nanoparticles. The targeted delivery allows for higher drug doses to be used against cancer cells.
3. The review discusses both preventative and treatment applications of nanotechnology. Preventatively, nanoparticles could deliver sunscreen agents directly to skin cells. In treatment, nanoparticles are being used to more effectively deliver drugs like paclitaxel for prostate cancer therapy.
Nanoparticle (NP) Delivery of Chemotherapy
Drugs to Prostate Cancer Patients by Toluleke Oloruntobi Famuyiwa* and James Kwasi Kumi-Diaka in Integrative Journal of Conference Proceedings
Nanotechnology is being used in the field of nanomedicine to develop targeted drug delivery systems, diagnostic tools, and regenerative medicine applications at the molecular scale. Nanomedicine exploits the unique properties of nanomaterials to enable early disease detection, improved diagnosis and imaging, and more effective treatments. Some examples include using nanoparticles to specifically deliver anti-cancer drugs to tumor cells, developing magnetic nanoparticles that can be used to track stem cells via MRI, and creating smart biomaterials that promote tissue self-healing. Nanomedicine shows promise for solving health issues like cancer, diabetes, and neurodegenerative diseases.
Nanoparticles in lung cancer treatment and diagnosis.mohamedAhmed1628
1. The document discusses recent advances in using nanoparticles for the diagnosis and treatment of lung cancer.
2. It outlines different types of nanoparticles like liposomes, polymer nanoparticles, dendrimers, gold nanoparticles, and silica nanoparticles that have been used to target lung cancer cells and enhance drug delivery.
3. Recent applications show these nanoparticles can help increase drug concentrations in tumors, induce cancer cell apoptosis, and selectively target cancer cells while reducing side effects - showing promise for improved lung cancer treatment.
Biofield Treatment: An Alternative Approach to Combat Multidrug-Resistant Sus...Mahendra Kumar Trivedi
As biofield therapy is increasingly popular in biomedical heath care, so present study aimed to evaluate the impact of Mr. Trivedi’s biofield treatment on antimicrobial sensitivity, minimum inhibitory concentration (MIC), biochemical study, and biotype number of multidrug resistant strain of R. ornithinolytica.
Biofield Treatment: An Alternative Approach to Combat Multidrug-Resistant Sus...albertdivis
As biofield therapy is increasingly popular in biomedical heath care, so present study aimed to evaluate the impact of Mr. Trivedi’s biofield treatment on antimicrobial sensitivity, minimum inhibitory concentration (MIC), biochemical study, and biotype number of multidrug resistant strain of R. ornithinolytica.
Similar to Drug Delivery : Wiley-VCH Hot Topics (20)
Biofield Treatment: An Alternative Approach to Combat Multidrug-Resistant Sus...
Drug Delivery : Wiley-VCH Hot Topics
1. Drug Delivery
The importance of drug delivery to chemists, medicinal and otherwise, has increased
since the advent of integrated drug discovery processes. Physicochemical and
biological barriers, pathways for drug delivery, formulation, pharmacokinetic and
pharmacodynamic issues, metabolism, and cell culture models used in studying drug
delivery are just some of the topics that make drug delivery an exciting field for
researchers.
Find all articles on drug delivery in Wiley Online Library...
Recent Articles
RSS feed
Targeted Drug Delivery: Liposome-Loaded Cell Backpacks (Adv. Healthcare Mater. 18/2015)
Cellular backpacks are circular 7μm-wide polymer patches that can be adhered to the surface of
living cells. The image shows backpacks containing liposomes loaded with the anticancer drug
doxorubicin (red) attached to the surface of living monocytes. More details are provided on page
2832 by M.F. Rubner and co-workers.
[Frontispiece]
Roberta Polak, Rosanna M. Lim, Marisa M. Beppu, Ronaldo N. M. Pitombo, Robert E. Cohen,
Michael F. Rubner
Adv. Healthcare Mater., December 28, 2015, DOI: 10.1002/adhm.201570104. Read article
A Divalent PAMAM-Based Matrix Metalloproteinase/Carbonic Anhydrase Inhibitor for the Treatment of Dry Eye
Syndrome
It’s all in the delivery: The inhibitor shown here is a nanomolar, dendron-based
divalent sulfonamide that can bind gelatinase (MMP-9), the most important MMP on
the ocular surface, and the transmembrane human carbonic anhydrase XII, present
in eyes and considered an antiglaucoma target. In an animal model of a dry eye, no
evidence of corneal desiccation was observed in eyes treated with our inhibitor.
[Full Paper]
B. Richichi, V. Baldoneschi, S. Burgalassi, M. Fragai, D. Vullo, A. Akdemir, E.
Dragoni, A. Louka, M. Mamusa, D. Monti, D. Berti, E. Novellino, G. De Rosa, C. T.
Supuran, C. Nativi
Chem. Eur. J., December 22, 2015, DOI: 10.1002/chem.201504355. Read article.
Controlled Multi-functionalization Facilitates Targeted Delivery of Nanoparticles to Cancer Cells
Through the barricades: Controlled multi-functionalization of nanoparticles with
2. a cytotoxic drug, a glycan ligand for the cell surface receptor CD22, and an
imaging moiety led to a remarkable 60-fold enhancement in cytotoxicity of CD22
(+) lymphoma cells compared to non-targeted nanoparticles.
[Full Paper]
Manish S. Hudlikar, Xiuru Li, Ivan A. Gagarinov, Nagesh Kolishetti, Margreet A.
Wolfert, Geert-Jan Boons
Chem. Eur. J., December 18, 2015, DOI: 10.1002/chem.201503999. Read article.
Ruthenium-Containing Block Copolymer Assemblies: Red-Light-Responsive Metallopolymers with Tunable
Nanostructures for Enhanced Cellular Uptake and Anticancer Phototherapy
Self-assembled nanostructures of red-light-responsive Ru(II)-containing block
copolymers are used for anticancer phototherapy. The Ru complexes in the block
copolymers are photocleavable and anticancer agents. Red light releases the Ru
complexes and generates singlet oxygen in cancer cells. A moderate irradiation dose,
which prevents photodamage, is sufficient to inhibit the growth of cancer cells.
[Full Paper]
Wen Sun, Maria Parowatkin, Werner Steffen, Hans-Jürgen Butt, Volker Mailänder, Si Wu
Adv. Healthcare Mater., December 17, 2015, DOI: 10.1002/adhm.201500827. Read
article
Glutathione Bioresponsive Cyclodextrin Nanosponges
Cyclodextrin-based nanosponges: A
new one-step synthetic route for the
production of glutathione (GSH)-
responsive nanosponges was reported.
The system can encapsulate the
anticancer drug doxorubicin and release it
as a function of external GSH
concentration. In vitro and in vivo studies
showed an increase in effectiveness of
anticancer drugs encapsulated within the
nanosponge (see figure).
[Communication]
Francesco Trotta, Fabrizio Caldera, Chiara Dianzani, Monica Argenziano, Giuseppina Barrera, Roberta Cavalli
ChemPlusChem, December 15, 2015, DOI: 10.1002/cplu.201500531. Read article
Coordination Polymers Derived from Non-Steroidal Anti-Inflammatory Drugs for Cell Imaging and Drug Delivery
Coordinated functions: A series of MnII-based coordination polymers were derived
from different non-steroidal anti-inflammatory drugs (NSAIDs), which showed
excellent cell imaging, in vitro anti-inflammatory and drug delivery properties (see
figure).
[Full Paper]
Mithun Paul, Parthasarathi Dastidar
Chem. Eur. J., December 11, 2015, DOI: 10.1002/chem.201503706. Read article.
Near-Infrared Light-Triggered Intracellular Delivery of Anticancer Drugs Using Porous Silicon Nanoparticles
Conjugated with IR820 Dyes
Porous silicon nanoparticles conjugated with IR820 dyes trigger excellent intracellular drug release with near-infrared
laser irradiation.
[Full Paper]
Bing Xia, Bin Wang, Zhenyu Chen, Qi Zhang, Jisen Shi
3. Adv. Mater. Interfaces, December 10, 2015, DOI: 10.1002/admi.201500715. Read article
Selective Killing of Breast Cancer Cells by Doxorubicin-Loaded Fluorescent Gold Nanoclusters: Confocal
Microscopy and FRET
Licence to kill: This study shows the real-time release (delivery) of the anticancer
drug doxorubicin from gold nanoclusters (AuNCs) carrier inside cancer and noncancer
cells. The use of doxorubicin-loaded AuNCs leads to the selective killing of breast
cancer cells (MCF7), significantly increases the survival rate of noncancer breast cells
(MCF10A), and shows strong potential as a breast cancer cell specific therapeutic
material with minimal side effects.
[Article]
Shyamtanu Chattoraj, Asif Amin, Batakrishna Jana, Saswat Mohapatra, Surajit
Ghosh, Kankan Bhattacharyya
ChemPhysChem, December 04, 2015, DOI: 10.1002/cphc.201500982. Read article
Liposome-Loaded Cell Backpacks
Liposomes loaded with doxorubicin are successfully embedded into cell
backpacks with retention of their structure. Liposome-loaded backpacks are attached
to the surface of living monocytes, which remain viable over timescales relevant to usual
drug delivery schemes. An interesting observation suggests a potential new use of cell
backpacks as vectors for the direct targeting of cancer cells.
[Full Paper]
Roberta Polak, Rosanna M. Lim, Marisa M. Beppu, Ronaldo N. M. Pitombo, Robert E. Cohen, Michael F. Rubner
Adv. Healthcare Mater., November 30, 2015, DOI: 10.1002/adhm.201500604. Read article
Photoinduced Dynamics and Toxicity of a Cancer Drug in Proximity of Inorganic Nanoparticles under Visible
Light
Given the green light: Rose bengal in conjugation with zinc oxide nanoparticles
(ZnO NPs) enhances the generation of reactive oxygen species (ROS) upon
green-light irradiation in comparison with the free drug. Detailed spectroscopic
investigations were performed and the in vitro toxicity of the nanohybrid was
confirmed using various cell lines.
[Article]
Siddhi Chaudhuri, Samim Sardar, Damayanti Bagchi, Shreyasi Dutta, Sushanta
Debnath, Partha Saha, Peter Lemmens, Samir Kumar Pal
ChemPhysChem, November 26, 2015, DOI: 10.1002/cphc.201500905. Read
article
Gelatin-Assisted Synthesis of Vaterite Nanoparticles with Higher Surface Area and Porosity as Anticancer Drug
Containers In Vitro
Holey vaterite nanoparticles! Porous vaterite nanoparticles (VNs) fabricated with gelatin assistance displayed high
surface area and improved stability in aqueous solution. Their application as doxorubicin containers and their therapeutic
efficacy against cancer cells were investigated in vitro. The vaterite nanoparticles
4. prove to be excellent containers for anticancer drugs after modification by folic acid.
[Full Paper]
Anhe Wang, Yang Yang, Xiaoming Zhang, Xingcen Liu, Wei Cui, Junbai Li
ChemPlusChem, November 24, 2015, DOI: 10.1002/cplu.201500515. Read article
An Apoferritin-based Drug Delivery System for the Tyrosine Kinase Inhibitor Gefitinib
Anticancer drug Gefitinib encapsulated within human heavy chain apoferritin by
diffusion allows pH-controlled sustained release of cargo. The combination of increased
cellular uptake, and potent and enhanced antitumor activity against the HER2
overexpressing SKBR3 cell line compared to Gefitinib alone, makes it a promising carrier
for delivery of drugs to tumor sites.
[Communication]
Anchala I. Kuruppu, Lei Zhang, Hilary Collins, Lyudmila Turyanska, Neil R. Thomas,
Tracey D. Bradshaw
Adv. Healthcare Mater., November 23, 2015, DOI: 10.1002/adhm.201500389. Read
article
Polydopamine-Functionalized Superparamagnetic Magnetite Nanocrystal Clusters – Rapid Magnetic Response
and Efficient Antitumor Drug Carriers
Magnetite nanocrystal clusters (MNCs) are fabricated by a self-assembly strategy,
the surface of the MNCs is functionalized with polydopamine (PDOPA), and the
antitumor drug epirubicin is attached onto the surface. The achieved
MNC@PDOPA exhibits superparamagnetic characteristics, improved
magnetization behavior under external magnetic field, well-controlled loading, and
pH-responsive properties.
[Full Paper]
Shaokun Song, Wanting Zhu, Chao Long, Yang Zhang, Shun Chen, Lijie Dong
Eur. J. Inorg. Chem., November 18, 2015, DOI: 10.1002/ejic.201500912. Read
article.
Biomedical Applications of Functionalized ZnO Nanomaterials: from Biosensors to Bioimaging
Recent developments for ZnO nanostructures are presented, highlighting great
potential for biomedical applications such as biosensing, tissue regeneration, bioimaging,
and drug delivery.
[Review]
Ping Zhu, Zhengyang Weng, Xia Li, Xiangmei Liu, Shuilin Wu, K. W. K. Yeung, Xianbao
Wang, Zhenduo Cui, Xianjin Yang, Paul. K. Chu
Adv. Mater. Interfaces, October 29, 2015, DOI: 10.1002/admi.201500494. Read article
Versatile Protein Nanogels Prepared by In Situ Polymerization
The in situ polymerized nanogels with encapsulated proteins have great promises
for storage and release of cargos in a spatial, temporal, and dosage-controlled manner.
The preparation method and stimuli-responsive properties of the protein nanogels are
listed and explained herein.
[Talents & Trends]
Yanqi Ye, Jicheng Yu, Zhen Gu
Macromol. Chem. Phys., October 27, 2015, DOI: 10.1002/macp.201500296. Read article
Dermal Patch with Integrated Flexible Heater for on Demand Drug Delivery
A wearable drug delivery system based on a hydrogel sheet containing thermoresponsive drug carriers
interfaced with a flexible heater is engineered for topical applications. The platform maintains a conformal contact
5. with skin and enables on demand and tunable drug delivery by controlling the hydrogel
temperature. The release rates of various molecules with different sizes are studied. The
system paves the way toward engineering smart wound dressings.
[Full Paper]
Sara Bagherifard, Ali Tamayol, Pooria Mostafalu, Mohsen Akbari, Mattia Comotto, Nasim
Annabi, Masoumeh Ghaderi, Sameer Sonkusale, Mehmet R. Dokmeci, Ali
Khademhosseini
Adv. Healthcare Mater., October 26, 2015, DOI: 10.1002/adhm.201500357. Read article
Pentafluorophenyl Ester-based Polymersomes as Nanosized Drug-Delivery Vehicles
The formation of polymersomes from HPMA-related amphiphilic blockcopolymers
is presented. These polymers are prepared via activated ester chemistry, which allows
efficient and facile modification. The vesicles formed from them exhibit high
encapsulation efficiencies for hydrophilic cargo via dual centrifugation. Furthermore, they
prove to be biocompatible, which makes them promising candidates as nanosized drug
carriers.
[Communication]
Martin Scherer, Karl Fischer, Frank Depoix, Thomas Fritz, Raphael Thiermann, Kristin Mohr, Rudolf Zentel
Macromol. Rapid Commun., October 19, 2015, DOI: 10.1002/marc.201500444. Read article
Thermo/pH Dual Responsive Mixed-Shell Polymeric Micelles Based on the Complementary Multiple Hydrogen
Bonds for Drug Delivery
Join the DOX: Thermo/pH dual responsive mixed-shell polymeric micelles based
on the complementary multiple hydrogen bonds are synthesized. The collapsed
poly(N-vinylcaprolactam) (PNVCL) shell could form hydrophobic domains on the
poly(ɛ-caprolactone) (PCL) core and the corona formed by the water soluble
methoxy poly(ethylene glycol) (MPEG) chains was embedded into the PNVCL shell
and acted as a channel and a protective barrier against aggregation of the micelles.
[Full Paper]
Qiuhua Wu, Xiuping Tang, Xue Liu, Yu Hou, He Li, Chen Yang, Jie Yi, Ximing
Song, Guolin Zhang
Chem. Asian J., October 15, 2015, DOI: 10.1002/asia.201500847. Read article
Photomediated Reactive Oxygen Species-Generable Nanoparticles for Triggered Release and Endo/Lysosomal
Escape of Drug upon Attenuated Single Light Irradiation
Photomediated reactive oxygen species (ROS)-generable nanoparticles (SRNs)
incorporated with ROS-generator and scavenger in a single delivery platform is
developed. Under attenuated single light irradiation, doxorubicin loaded SRNs (D-SRNs)
synergistically exhibit simultaneous triggered drug release and endo/lysosomal escape
as well as photodynamic therapy for highly efficient cancer treatment.
[Full Paper]
Eun Ha Seo, Chung-Sung Lee, Kun Na
Adv. Healthcare Mater., October 09, 2015, DOI: 10.1002/adhm.201500622. Read article
Grafting of ZnS:Mn-Doped Nanocrystals and an Anticancer Drug onto Graphene Oxide for Delivery and Cell
Labeling
New inroads in theranostics: The grafting of fluorescent ZnS:Mn-doped nanocrystals and
the anticancer drug doxorubicin onto graphene oxide can be used for cell labeling and drug
delivery applications. The nanocomposite particles exhibit drug entrapment efficiency of
100% and cancer cell killing efficiency of 85%. The particles label the perinuclear region of
HeLa cells with yellow fluorescence (see figure).
[Full Paper]
Sanghamitra Dinda, Mitali Kakran, Jialiu Zeng, Thankiah Sudhaharan, Sohail Ahmed,
Debajyoti Das, Subramanian Tamil Selvan
ChemPlusChem, September 01, 2015, DOI: 10.1002/cplu.201500349. Read article